Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
Lincoln Electric (NASDAQ:LECO) Raised to Buy at StockNews.com
Lincoln Electric (NASDAQ:LECO – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a...
Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research note...
Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at StockNews.com
Research analysts at StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Get Free Report) in a report issued...
RiceBran Technologies (NASDAQ:RIBT) Coverage Initiated by Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of RiceBran Technologies (NASDAQ:RIBT – Get Free Report) in a research report...
Barnwell Industries (NYSE:BRN) Now Covered by StockNews.com
Investment analysts at StockNews.com began coverage on shares of Barnwell Industries (NYSE:BRN – Get Free Report) in a research report...
UBS Group Upgrades Hugo Boss (OTCMKTS:BOSSY) to “Buy”
UBS Group upgraded shares of Hugo Boss (OTCMKTS:BOSSY – Free Report) from a neutral rating to a buy rating in...